Markedly elevated CA19-9 associated with benign ovarian cyst and ascites

A 60-year-old woman presented after a fall and was noted to have ascites. She had a history of ulcerative colitis. History and physical examination did not reveal the likely aetiology of the ascites, but a sample showed it to be a blood-stained exudate. A malignant cause appeared likely, cross-sectional imaging was arranged and tumour markers sent. CA125 was 34 IU/ml (0–30); &agr;-fetoprotein (AFP) and carcinoembryonic antigen (CEA) were normal. However, CA19-9 was 2880 U/ml (0–31). Pancreatic carcinoma or cholangiocarcinoma were of prime concern, but a CT scan and MRI imaging were normal. At laparoscopy a benign ruptured ovarian cyst was detected, and ascites drained. CA19-9 returned to normal and the patient remains well 9 months later. This case demonstrates how tumour markers may be misleading in the context of diagnostics, and is the highest reported example of CA19-9 rise in the context of benign ascites and benign ovarian pathology.

[1]  M. Santis,et al.  Tumour markers in internal medicine: a low-cost test or an unnecessary expense? A retrospective study based on appropriateness , 2007, Internal and emergency medicine.

[2]  Shakir Ali,et al.  Increased serum carcinomic antigen 19-9(CA 19-9) in a dermoid cyst , 2007, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.

[3]  V. Heinemann,et al.  Prognostic and Therapeutic Significance of Carbohydrate Antigen 19-9 as Tumor Marker in Patients with Pancreatic Cancer , 2006, Oncology.

[4]  C. Atabekoğlu,et al.  Elevated carbohydrate antigen 19‐9 in a dermoid cyst , 2005, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[5]  S. Loi,et al.  Towards evidence‐based use of serum tumour marker requests: an audit of use in a tertiary hospital , 2004, Internal medicine journal.

[6]  A. Sevinç,et al.  The importance of serum and ascites fluid alpha-fetoprotein, carcinoembryonic antigen, CA 19-9, and CA 15-3 levels in differential diagnosis of ascites etiology. , 2001, Hepato-Gastroenterology.

[7]  Shou-Dong Lee,et al.  Clinical value of tumour markers and serum‐ascites albumin gradient in the diagnosis of malignancy‐related ascites , 1994, Journal of gastroenterology and hepatology.

[8]  M. Herlyn,et al.  Specific antigen in serum of patients with colon carcinoma. , 1981, Science.

[9]  K. Takahashi,et al.  Abnormally high values of CA 125 and CA 19-9 in women with benign tumors. , 1989, Gynecologic and obstetric investigation.